1496 Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 

national, state, and local prevention 

priorities. 

This Revision includes an update to 

add three diseases included as part of 

Form 57.130—Pathogens of High 

Consequence. The original collection 

captured the number of patients newly 

admitted and currently hospitalized 

with certain diseases in acute care 

hospitals (e.g.,. Crimean-Congo 

Hemorrhagic Fever (CCHF), Dengue, 

Ebola, Lassa, Measles, Mpox, MERSCoV, Nipah, and Toxigenic Vibrio 

cholerae) broken down by adult patients 

and pediatric patients. Three additional 

diseases are being added to the data 

collection, Influenza A (H5), Marburg, 

and Oropouche. Influenza A (H5) has 

been on the CDC’s Office of Readiness 

and Response website as an active 

response. Marburg and Oropouche were 

recently added to the website as active 

responses due to international 

outbreaks. It is crucial for CDC to be 

aware of cases of these select infectious 

diseases of public health concern to 

help ensure that local and state 

authorities are equipped to contain and 

prevent further spread. Facilities 

enrolled in the NHSN Patient Safety 

Component will be asked to select the 

specific diseases they are reporting on 

and then provide the overall number of 

patients hospitalized with confirmed 

disease along with stratification of 

disease in adult and pediatric patients. 

The data collection will be collected 

electronically via the NHSN application. 

This Revision requests OMB approval 

for an estimated 111,021 annual burden 

hours to be added to Form 57.130— 

Pathogens of High Consequence. The 

total estimated annual burden hours for 

the NHSN package will be increased to 

4,508,255. Participation is required for 

healthcare facilities that report through 

the NHSN platform. There is no cost to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Infection Preventionist/Microbiologist 57.130 Pathogens of High Consequence.3,650 365 5/60 111,021 

Total ........................................... ........................................................... ........................ ........................ ........................ 4,508,255 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00165 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–0469; Docket No. CDC–2024– 

0105] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled National 

Program of Cancer Registries Cancer 

Surveillance System. This information 

collection creates a Cancer Registry that 

provides useful data on cancer 

incidence, trends, and outcomes. 

DATES: CDC must receive written 

comments on or before March 10, 2025. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0105 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road, NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road, NE, MS– 

D74, Atlanta, Georgia 30329; Telephone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 1497 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

National Program of Cancer Registries 

Cancer Surveillance System (OMB 

Control No. 0920–0469, Exp. 1/31/ 

2026)—Revision—National Center for 

Chronic Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

In 2021, the most recent year for 

which complete incidence information 

is available, almost 620,000 people died 

of cancer and more than 1.8 million 

were diagnosed with cancer. It is 

estimated that 17 million Americans are 

currently alive with a history of cancer. 

In the U.S., State/Territory-based central 

cancer registries (CCR) are the only 

method for systematically collecting and 

reporting population-based information 

about cancer incidence and outcomes 

such as survival. These data are used to 

measure the changing incidence and 

burden of each cancer; identify 

populations at increased or increasing 

risk; target preventive measures; and 

measure the success or failure of cancer 

control efforts in the United States. 

In 1992, Congress passed the Cancer 

Registries Amendment Act which 

established the National Program of 

Cancer Registries (NPCR). The NPCR 

provides support for State/Territorybased cancer registries that collect, 

manage, and analyze data about cancer 

cases. The State/Territory-based cancer 

registries report information to CDC 

through the National Program of Cancer 

Registries Cancer Surveillance System 

(NPCR CSS), (OMB Control No. 0920– 

0469). CDC plans to request OMB 

approval to continue collecting this 

information for three years. Data 

definitions will be updated to reflect 

changes in national standards for cancer 

diagnosis and coding. No changes to the 

total estimated annualized burden hours 

or number of respondents are 

anticipated. 

The NPCR CSS allows CDC to collect, 

aggregate, evaluate, and disseminate 

cancer incidence data at the national 

level. The NPCR CSS is the primary 

source of information for the United 

States Cancer Statistics (USCS), which 

CDC has published annually since 2002. 

The latest USCS report published in 

2024 provided cancer statistics for 98% 

of the U.S. population from all cancer 

registries in the United States. Prior to 

the publication of USCS, cancer 

incidence data at the national level were 

available for only 14% of the population 

of the United States. The NPCR CSS also 

allows CDC to monitor cancer trends 

over time, describe geographic variation 

in cancer incidence throughout the 

country, and provide incidence data on 

populations by race, ethnicity, and other 

demographic and tumor characteristics 

and data on rare cancers. These 

activities and analyses further support 

CDC’s planning and evaluation efforts 

for state and national cancer control and 

prevention. In addition, datasets can be 

made available for secondary analysis. 

Respondents are NPCR-supported 

CCRs in 46 U.S. States, three Territories, 

and the District of Columbia. Fifty CCRs 

submit data elements specified for the 

Standard NPCR CSS Report. Each CCR 

is asked to transmit two data files to 

CDC per year. The first NPCR CSS 

Standard file, submitted in January, is a 

preliminary report consisting of one 

year of data for the most recent year of 

available data. CDC evaluates the 

preliminary data for completeness and 

quality and provides a report back to the 

CCR. The second NPCR CSS Standard 

file, submitted in November, contains 

cumulative cancer incidence data from 

the first diagnosis year for which the 

cancer registry collected data with the 

assistance of NPCR funds (e.g., 1995) 

through 12 months past the close of the 

most recent diagnosis year (e.g., 2022). 

The cumulative file is used for analysis 

and reporting. The burden for each file 

transmission is estimated at two hours 

per response. Because cancer incidence 

data are already collected and 

aggregated at the state level, the 

additional burden of reporting the 

information to CDC is small. 

All information is transmitted to CDC 

electronically. Participation is required 

as a condition of the cooperative 

agreement with CDC. CDC requests 

OMB approval for an estimated 200 

annual burden hours. There are no costs 

to respondents except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Central Cancer Registries in States, 

Territories, and the District of Columbia.

Standard NPCR CSS Report ........... 50 2 2 200 

Total ........................................... ........................................................... ........................ ........................ ........................ 200 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00163 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2025–0002] 

Establishing a Road Map for 

Accelerated Diagnosis and Treatment 

of HCV Infection in the United States 

AGENCY: Centers for Disease Control and 

Prevention, Health, and Human Services 

(HHS). 

ACTION: Notice of public meeting and 

request for comment. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) 

announces a two-day convening hosted 

and facilitated by the Association of 

Public Health Laboratories (APHL) to 

discuss hepatitis C diagnostics. Leaders 

from public health, laboratory, medical, 

academic, and industry sectors will 

have the opportunity to provide 

individual input, without building a 

consensus, on accelerating the diagnosis 

of current hepatitis C virus (HCV) 


lotter on DSK11XQN23PROD with NOTICES1